I am using IGV to view the mapped bam file to the reference- some genes have no coverage at all (no grey bars)- how could I know if these regions are absent from my genome (compared to the reference) or they were not sequenced at all?
-
-
You are not going to know for sure from data you have at hand. Here are a couple things to consider.
If you have good coverage on either side of the region you are not seeing then there is a chance that the region is absent in your genome (you will need to verify by additional experimentation).
If you do not have uniformly good depth of coverage across the genome then you would not know if a particular region was not sequenced. You would probably need to sequence deeper in that case. -
Igv
Yes- this makes senseOriginally posted by GenoMax View Post
I was wondering why I can see in IGV white bars at certain regions (not grey bars)?Comment
-
Their MAPQ is 0 (otherwise, they're grey or another color).Comment
-
-
Is this exome capture? If so I would check the regions are captured by the kit used in the first place. The bed files for the capture regions will be available from the manufacturer, and it may be that the regions might not be sequenced for this reason.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...Yesterday, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment